½ÃÀ庸°í¼­
»óǰÄÚµå
1804877

¹æ±¤°æ °Ë»ç ¹× ¿ä°ü°æ °Ë»ç ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2021-2031³â) : ¼¼°è¿Í Áö¿ª Á¡À¯À², µ¿Çâ, ¼ºÀå ±âȸ ºÐ¼® ¸®Æ÷Æ® - Á¦Ç° À¯Çüº°, ½Ã¼úº°, ±â¼úº°, »ç¿ë À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°

Cystoscopy and Ureteroscopy Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Procedure, Technology, Usage Type, End User, and Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Insight Partners | ÆäÀÌÁö Á¤º¸: ¿µ¹® 305 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¹æ±¤°æ °Ë»ç¡¤¿ä°ü°æ °Ë»ç ½ÃÀåÀº 2024³â 4¾ï 5,911¸¸ ´Þ·¯¿¡¼­ 2031³â±îÁö´Â 7¾ï 2,930¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖÀ¸¸ç, 2025-2031³âÀÇ CAGRÀº 6.9%·Î ¿¹ÃøµË´Ï´Ù. ¹æ±¤°æ ¹× ¿ä°ü°æ °Ë»ç ½ÃÀåÀÇ ¼ºÀåÀº ³­Ã» À¯º´·ü Áõ°¡¿Í ½ÃÀå ±â¾÷ÀÇ Àü·«Àû ±¸»óÀÇ ±ÞÁõ¿¡ ±âÀÎÇÕ´Ï´Ù.

¹æ±¤°æ °Ë»ç ¹× ¿ä°ü°æ °Ë»ç´Â Çö´ë ºñ´¢±â°ú ÀÇ·áÀÇ ÃÖÀü¼±¿¡ ÀÖÀ¸¸ç, ´Ù¾çÇÑ ¿ä·Î ÁúȯÀÇ Áø´Ü ¹× Ä¡·á¸¦ À§ÇÑ Ç¥ÀûÈ­µÈ ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ½Ã¼úÀº °íÇØ»óµµ Ä«¸Þ¶ó¿Í Á¶¸í ½Ã½ºÅÛÀ» °®Ãá ¿¬¼º ¹× °æ¼º ³»½Ã°æÀ» »ç¿ëÇÏ¿© ÃÖ÷´Ü ±â¼úÀ» Ȱ¿ëÇÏ¿© ÀÓ»óÀǰ¡ ¹æ±¤°ú ¿äµµ¸¦ ºñ±³ÇÒ ¼ö ¾øÀ» Á¤µµ·Î Àß º¼ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù.

ºÏ¹Ì ¹æ±¤°æ °Ë»ç ¹× ¿ä°ü°æ °Ë»ç ½ÃÀåÀº ¹Ì±¹, ij³ª´Ù, ¸ß½ÃÄÚ·Î ±¸ºÐµË´Ï´Ù. ºÏ¹Ì ¹æ±¤°æ ¹× ¿ä°ü°æ °Ë»ç ½ÃÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¹Ì±¹ÀÌ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖÀ¸¸ç, ij³ª´Ù°¡ ±× µÚ¸¦ ÀÕ°í ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀÇ ¹æ±¤°æ ¹× ¿ä°ü°æ °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä´Â ½ÅÀå°á¼®(¿ä·Î°á¼®Áõ), ¹æ±¤¾Ï, ¿ä·Î°¨¿°ÁõÀÇ ¹ßº´·ü Áõ°¡¿¡ ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù.

û»ö±¤ ¹æ±¤°æ°ú °°Àº ÷´Ü ±â¼úÀº ±âÁ¸ÀÇ ¹é»ö±¤ÀÌ Á¦°øÇÒ ¼ö ÀÖ´Â °Í ÀÌ»óÀ¸·Î ¹æ±¤¾Ï º´º¯ÀÇ °¡½Ã¼ºÀ» °­È­ÇÕ´Ï´Ù. ¶ÇÇÑ ¿ä°ü°æ °Ë»ç Áß °á¼® ºÐ¼â¸¦ À§ÇÑ ·¹ÀÌÀú ½Ã½ºÅÛÀÇ ÅëÇÕÀº º¸´Ù Áøº¸µÈ Áø´Ü ¹× Ä¡·á ¿É¼ÇÀ¸·ÎÀÇ ÀüȯÀ» °­Á¶Çϰí ÀÖ½À´Ï´Ù. ·Îº¿ °øÇÐ ¹× ¹«¼± ¿¬°áÀº Á¤È®¼º, ÀÎü°øÇÐ, ¿ø°Ý Áø´Ü ´É·ÂÀ» Çâ»ó½Ãŵ´Ï´Ù. Olympus, KARL STORZ, Boston Scientific, FUJIFILM µî ÁÖ¿ä ÀÇ·á±â±â ¾÷üµéÀº Áö¼ÓÀûÀÎ ¿¬±¸°³¹ß°ú Àü·«Àû Á¦ÈÞ¸¦ ÅëÇØ Á¦Ç° Ãâ½Ã¿Í ½ÃÀå ħÅõ¸¦ °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù.

ºÏ¹Ì¿¡¼­´Â ¹Ì±¹ÀÌ ¹æ±¤°æ °Ë»ç ¹× ¿ä°ü°æ °Ë»ç ½ÃÀå¿¡¼­ Å« ºñÁßÀ» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. 2024³â ºÏ¹Ì ¹æ±¤°æ ¹× ¿ä°ü°æ °Ë»ç ½ÃÀåÀº ¹Ì±¹ÀÌ ÁÖµµÇß½À´Ï´Ù. Ç÷θ®´Ù ´ëÇÐ ºñ´¢±â°ú¿¡ µû¸£¸é ¹Ì±¹¿¡¼­´Â ¸Å³â 500¸í Áß 1¸í²Ã·Î ½ÅÀå °á¼®ÀÌ ¹ß»ýÇÑ´Ù°í ÇÕ´Ï´Ù. ³²¼ºÀÇ °æ¿ì ¾à 8¸í Áß 1¸í, ¿©¼ºÀÇ °æ¿ì ¾à 16¸í Áß 1¸íÀÌ ÀÏ»ý µ¿¾È ½ÅÀå °á¼®À» ¾Î°í ÀÖ½À´Ï´Ù. ½ÅÀå °á¼® À¯º´·ü Áõ°¡´Â Á¶±â Áø´Ü ¹× Ä¡·á¸¦ À§ÇÑ ¹æ±¤°æ °Ë»ç ¹× ¿ä°ü°æ °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù.

¹Ì±¹ ±¹¸³ ÀÇÇÐ µµ¼­°ü¿¡ µû¸£¸é ¿ä·Î°á¼®Àº ¹Ì±¹¿¡¼­ °¡Àå ÈçÇÑ ¿Ü·¡ °¨¿° ÁúȯÀÔ´Ï´Ù. ¿ä·Î°á¼®ÀÇ ¹ß»ýÀº ÀϹÝÀûÀ¸·Î ³ªÀ̰¡ µé¸é¼­ Áõ°¡ÇÕ´Ï´Ù. 65¼¼ ÀÌ»ó ¿©¼ºÀÇ ¾à 20%°¡ ¿ä·Î°á¼®À» °æÇèÇÑ ¹Ý¸é, Àüü Àα¸ÀÇ ¾à 11%´Â ¿ä·Î°á¼®À» °æÇèÇϰí ÀÖ½À´Ï´Ù. ÀϹÝÀûÀ¸·Î ¼ºÀÎ ¿©¼ºÀÇ 50-60% Á¤µµ°¡ ÀÏ»ý¿¡ ÇÑ ¹ø ÀÌ»ó ¿ä·Î°á¼®¿¡ °É¸³´Ï´Ù.

¹Ì±¹³» ¹æ±¤°æ ¹× ¿ä°ü°æ °Ë»çÀÇ ÃÖ±Ù µ¿ÇâÀº º¸´Ù ÃÖ¼Òħ½ÀÀûÀ̰í Á¤È®Çϸç ȯÀÚ Áß½ÉÀÇ Ä¡·á¸¦ °¡´ÉÇÏ°Ô ÇÏ´Â ±â¼úÀû Ãø¸éÀÌ ÁÖ¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ·Îº¿ ¹æ±¤°æÀÌ ÀÇ·á ºÐ¾ß¿¡¼­ Àα⸦ ²ø°í ÀÖÀ¸¸ç, ÀÏȸ¿ë ¹× ·Îº¿ Áö¿ø ½Ã½ºÅÛÀ» ÅëÇØ ¹æ±¤°æ °Ë»ç°¡ ¹ßÀüÇϰí ÀÖ½À´Ï´Ù. 2024³â 8¿ù, PROCEPT BioRobotics CorporationÀº Â÷¼¼´ë Ç÷§ÆûÀÎ HYDROS Robotic SystemÀÇ FDA 510(k) ½ÂÀÎÀ» ¹ßÇ¥Çß½À´Ï´Ù. HYDROS Robotic SystemÀº Àü¸³¼±ºñ´ëÁõ(BPH)¿¡ ´ëÇÑ Aquablation Ä¡·á¸¦ À§ÇÑ À¯ÀÏÇÑ AI žÀç Ç÷§ÆûÀÔ´Ï´Ù. ÀÌ ÀÔÁõµÈ Ä¡·á¹ýÀº ½Ç½Ã°£ ÃÊÀ½ÆÄ ¹× ¹æ±¤°æÀ» »ç¿ëÇÏ¿© Àü¸³¼±À» ÀÚ¼¼È÷ º¼ ¼ö ÀÖµµ·Ï µµ¿ÍÁÖ¸ç, ¸ÂÃã Ä¡·á¸¦ °¡´ÉÇÏ°Ô ÇÏ´Â °ËÁõµÈ Ä¡·á¹ýÀÔ´Ï´Ù. 400´ë ÀÌ»óÀÇ ·Îº¿ ½Ã½ºÅÛÀÌ ¼³Ä¡µÇ¾î ÀÖÀ¸¸ç, Aquablation Ä¡·á´Â ¹Ì±¹¿¡¼­ Å« Àα⸦ ¾ò°í ÀÖ½À´Ï´Ù.

Karl Storz, Olympus, Stryker, Richard Wolf µî ¾÷°è¸¦ ´ëÇ¥ÇÏ´Â ±â¾÷ÀÇ ¿µ»óó¸® ±â´ÉÀ» °­È­Çϰí Áö¸§À» ÁÙÀÎ ¿¬¼º ¿ä°ü°æ °³¹ßÀº ºñ´¢±â°ú ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» Å©°Ô °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀû Áøº¸´Â ½Ã¼úÀÇ Å½»öÀ» °³¼±Çϰí, ȯÀÚÀÇ ºÒÆíÇÔÀ» ÁÙÀ̸ç, ½Ã¼ú Áß ½Ã°¢Àû ¼±¸íµµ¸¦ Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ¿Ã¸²Çª½º´Â 2024³â 4¿ù, Çõ½ÅÀûÀÎ ÀÏȸ¿ë ¿ä°ü°æ ½Ã½ºÅÛ RenaFlex¿¡ ´ëÇÑ ¹Ì±¹ ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎÀ» ȹµæÇß½À´Ï´Ù. ÀÌ ÃÖ÷´Ü ¼Ö·ç¼ÇÀº °æ¿äµµ ¶Ç´Â °æÇÇÀû ½Ã¼úÀ» ÅëÇØ ½ÅÀå °á¼® µîÀÇ Áø´Ü ¹× Ä¡·á¸¦ À§ÇØ ¿ä·Î¿¡ È¿À²ÀûÀ¸·Î Á¢±ÙÇÒ ¼ö ÀÖµµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¿ä·Î ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ÀÌ·¯ÇÑ Ã·´Ü ÀÇ·á ±â¼úÀÇ Ãâ½Ã°¡ °áÇÕµÇ¾î ¹Ì±¹ ÇコÄÉ¾î »ê¾÷ Àüü¿¡¼­ ¹æ±¤°æ ¹× ¿ä°ü°æ ºÎ¹®ÀÌ Áö¼ÓÀûÀ¸·Î È®´ëµÇ°í ÀÖ½À´Ï´Ù.

·Îº¿ º¸Á¶ ºñ´¢±â°ú ¼ö¼ú·ÎÀÇ ÀüȯÀº ÇâÈÄ ½ÃÀå ±âȸ¸¦ °¡Á®¿Ã °ÍÀÔ´Ï´Ù.

·Îº¿ ¼ö¼ú, ƯÈ÷ ´ÙºóÄ¡ ¼ö¼ú ½Ã½ºÅÛÀÇ »ç¿ëÀº Á¤È®¼º, ÃÖ¼Ò Ä§½À¼º, ȸº¹ ½Ã°£ ´ÜÃà ´É·ÂÀ¸·Î ºñ´¢±â°ú ¼ö¼ú¿¡¼­ Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. ·Îº¿ ½Ã½ºÅÛÀº ¹æ±¤°æ °Ë»ç³ª ¿ä°ü°æ °Ë»ç¿Í °°Àº ¼¶¼¼ÇÑ ½Ã¼úÀ» ÇÒ ¶§ ¸Å¿ì Áß¿äÇÑ ¿Ü°ú Àǻ翡°Ô ´õ ³ªÀº Á¦¾î, Çâ»óµÈ °¡½Ã¼º, Çâ»óµÈ ¼ÕÀçÁÖ¸¦ Á¦°øÇÕ´Ï´Ù. º´¿øÀÇ Ã·´Ü ·Îº¿ Áö¿ø ½Ã½ºÅÛ ¶ÇÇÑ ÃÖ¼Ò Ä§½À ¼ö¼ú Áõ°¡¿¡ ±â¿©Çϰí ÀÖÀ¸¸ç, ºÒÆíÇÔÀ» ÁÙÀ̰í ÀÔ¿ø ±â°£À» ´ÜÃàÇϰí ȸº¹À» °¡¼ÓÈ­ÇÏ¿© ȯÀÚ¿¡°Ô ÇýÅÃÀ» Á¦°øÇÕ´Ï´Ù. 2024³â 8¿ù, PROCEPT BioRobotics CorporationÀº HYDROS ·Îº¿ ½Ã½ºÅÛÀÇ ½ÂÀÎÀ» ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ Â÷¼¼´ë Ç÷§ÆûÀº FirstAssist AI Ä¡·á °èȹ, °í±Þ ¿µ»ó ¾È³», ·Îº¿ ÀýÁ¦¼úÀ» Ư¡À¸·Î Çϸç, Àü¸³¼± ºñ´ëÁõ(BPH)¿¡ ´ëÇÑ ¼öÁß ÀýÁ¦¼úÀ» À§ÇÑ À¯ÀÏÇÑ AI ±â¹Ý ½Ã½ºÅÛÀÔ´Ï´Ù. ÀÌ Ä¡·á¹ýÀº ½Ç½Ã°£ ÃÊÀ½ÆÄ ¿µ»ó°ú ¹æ±¤°æÀ» °áÇÕÇÑ °ÍÀ¸·Î, ¼ö¼ú Àǻ翡°Ô Àü¸³¼±ÀÇ »ó¼¼ÇÑ ¿µ»óÀ» Á¦°øÇÏ¿© °³Àκ° ¸ÂÃã Ä¡·á °èȹÀ» ¼¼¿ï ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. ·Îº¿ ¼ö¼úÀº ÃâÇ÷À» ÁÙÀ̰í, ¼ö¼ú ½Ã°£À» ´ÜÃàÇϰí, ¼ö¼ú ÈÄ ÇÕº´ÁõÀ» ÁÙ¿© ÀÇ·áÁøÀÇ ºÎ´ãÀ» ´ú¾îÁÝ´Ï´Ù.

2024³â 5¿ù, º£ÀÌ·çÆ® ¾Æ¸Þ¸®Ä­ ´ëÇÐ ÀÇ·á¼¾ÅÍ ºñ´¢±â°ú´Â ½ÅÀå °á¼® Ä¡·á¸¦ À§ÇÑ ¿¬¼º ¿ä°ü°æ °Ë»ç¿¡ »ç¿ëµÇ´Â ILY ·Îº¿ ½Ã½ºÅÛÀÇ Ã¹ÀλóÀ» ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ ·Îº¿Àº ÀÎü°øÇÐÀû ¹«¼± Á¶À̽ºÆ½ ÄÁÆ®·Ñ·¯·Î Á¶À۵Ǹç, Xbox³ª PlayStation°ú °°Àº Àα⠰ÔÀÓ±âÀÇ ÄÁÆ®·Ñ·¯¿Í À¯»çÇÕ´Ï´Ù. ¼ö¼úÆÀÀÇ º¸°í¿¡ µû¸£¸é °á¼® Á¦°ÅÀ²Àº 93.55%À̸ç, Ä¡·áÇÑ °á¼®À¸·Î Àç¼ö¼úÀÌ ÇÊ¿äÇÑ È¯ÀÚ´Â ÇÑ ¸íµµ ¾ø¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ °á°ú·ÎºÎÅÍ ILY ·Îº¿½Ä ¿¬¼º ¿ä°ü°æÀº ¾ÈÀüÇϰí È¿°úÀûÀ̶ó´Â ÁÖÀåÀÌ Á¦±âµÇ°í ÀÖ½À´Ï´Ù. Àεµ¿Í °°Àº ½ÅÈï °æÁ¦±¹¿¡¼­´Â 2021³â ÇöÀç ¾à 76´ëÀÇ ¼ö¼ú¿ë ·Îº¿ÀÌ ¿Ïº®ÇÏ°Ô ÀÛµ¿Çϰí ÀÖÀ¸¸ç, 500¸í ÀÌ»óÀÇ ·Îº¿ ¼ö¼ú ÈÆ·ÃÀ» ¹ÞÀº ¿Ü°úÀǻ簡 ÀÖ½À´Ï´Ù. ¾Æ½Ã¾Æ½ÅÀåºñ´¢±â¿¬±¸¼Ò(AINU, Àεµ)´Â ¼¼°è ÃÖ°í ¼öÁØÀÇ ºñ´¢±â°ú Àü¹®º´¿øÀÔ´Ï´Ù. AINU´Â ·Îº¿ ¼ö¼ú, ƯÈ÷ Àü¸³¼± °ü·Ã Áúȯ ºÐ¾ßÀÇ Àü¹® Áö½ÄÀ¸·Î À¯¸íÇϸç, ·Îº¿ º¸Á¶ ¼ö¼ú¿¡ ´ëÇÑ ±³À°À» ¹ÞÀº ÃÖ°íÀÇ ¿Ü°ú ÀÇ»çµéÀÇ º»°ÅÁöÀÔ´Ï´Ù. ±â¼úÀÌ ´õ Àú·ÅÇϰí Ä£¼÷ÇØÁü¿¡ µû¶ó ¼Ò±Ô¸ð º´¿øÀ̳ª Áø·á¼Ò¿¡¼­µµ ·Îº¿ ½Ã½ºÅÛ¿¡ °ü½ÉÀ» º¸À̰í ÀÖ½À´Ï´Ù. ÀÌó·³ ·Îº¿º¸Á¶¼ö¼úÀÇ µµÀÔ È®´ë°¡ ¹æ±¤°æ °Ë»ç ¹× ¿ä°ü°æ °Ë»ç ½ÃÀåÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î ¶°¿À¸£°í ÀÖ½À´Ï´Ù.

¹Ì±¹ ½ÄǰÀǾ౹, ±¹Á¦¾Ï¿¬±¸¼Ò, ¹Ì±¹ ºñ´¢±â°úÇÐȸ, À¯·´ ºñ´¢±â°úÇÐȸ, ¾Æ½Ã¾Æ ºñ´¢±â°úÇÐȸ, ºñ´¢±â°úÇÐÀç´Ü µîÀº ¹æ±¤°æ °Ë»ç ¹× ¿ä°ü°æ °Ë»ç ½ÃÀå º¸°í¼­ ÀÛ¼º½Ã Âü°íÇÑ 1Â÷ ¹× 2Â÷ Á¤º¸ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå °³¿ä

  • ¾Ö³Î¸®½ºÆ® ½ÃÀå Àü¸Á
  • ½ÃÀåÀÇ ¸Å·Â

Á¦3Àå Á¶»ç ¹æ¹ý

  • 2Â÷ Á¶»ç
  • 1Â÷ Á¶»ç
    • °¡¼³ Ã¥Á¤
    • °Å½Ã°æÁ¦ ¿äÀÎ ºÐ¼®
    • ±â¹Ý ¼öÄ¡ÀÇ °³¹ß
    • µ¥ÀÌÅÍ »ï°¢Ãø·®
    • ±¹°¡ ·¹º§ µ¥ÀÌÅÍ
  • ÀüÁ¦Á¶°Ç°ú Á¦ÇÑ

Á¦4Àå ¹æ±¤°æ °Ë»ç¡¤¿ä°ü°æ °Ë»ç ½ÃÀå ±¸µµ

  • PEST ºÐ¼®

Á¦5Àå ¹æ±¤°æ °Ë»ç¡¤¿ä°ü°æ °Ë»ç ½ÃÀå - ÁÖ¿ä ½ÃÀå ¿ªÇÐ

  • ¹æ±¤°æ °Ë»ç¡¤¿ä°ü°æ °Ë»ç ½ÃÀå : ÁÖ¿ä ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ºñ´¢±â ÁúȯÀÇ À¯º´·ü Áõ°¡
    • ±â¼úÀû ÷´Ü ¹× Àúħ½À Á¦Ç°ÀÇ °³¹ß
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±â±â¿Í ½Ã¼úÀÇ °íºñ¿ë
  • ½ÃÀå ±âȸ
    • ½ÅÈï ½ÃÀå¿¡¼­ÀÇ È®´ë
  • ÇâÈÄ µ¿Çâ
    • ·Îº¿ Áö¿ø ºñ´¢±â°ú ¼ö¼ú·ÎÀÇ À̵¿
  • ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎÀÇ ¿µÇâ

Á¦6Àå ¹æ±¤°æ °Ë»ç¡¤¿ä°ü°æ °Ë»ç ½ÃÀå - ¼¼°è ½ÃÀå ºÐ¼®

  • ¹æ±¤°æ °Ë»ç¡¤¿ä°ü°æ °Ë»ç ½ÃÀå ¸ÅÃâ, 2021-2031³â
  • ¹æ±¤°æ °Ë»ç¡¤¿ä°ü°æ °Ë»ç ½ÃÀå ¿¹Ãø ºÐ¼®

Á¦7Àå ¹æ±¤°æ °Ë»ç¡¤¿ä°ü°æ °Ë»ç ½ÃÀå ºÐ¼® - Á¦Ç° À¯Çüº°

  • ¹æ±¤°æ
  • ¿ä°ü°æ

Á¦8Àå ¹æ±¤°æ °Ë»ç¡¤¿ä°ü°æ °Ë»ç ½ÃÀå ºÐ¼® - ½Ã¼úº°

  • °á¼® °ü¸®
  • ¹æ±¤¾Ï
  • Àü¸³¼± ºñ´ëÁõ(BPH)
  • ±âŸ

Á¦9Àå ¹æ±¤°æ °Ë»ç¡¤¿ä°ü°æ °Ë»ç ½ÃÀå ºÐ¼® - ±â¼úº°

  • ±¤¼¶À¯
  • ºñµð¿À

Á¦10Àå ¹æ±¤°æ °Ë»ç¡¤¿ä°ü°æ °Ë»ç ½ÃÀå ºÐ¼® - »ç¿ë À¯Çüº°

  • Àç»ç¿ë
  • ÀÏȸ¿ë

Á¦11Àå ¹æ±¤°æ °Ë»ç¡¤¿ä°ü°æ °Ë»ç ½ÃÀå ºÐ¼® - ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • Àü¹® Ŭ¸®´Ð

Á¦12Àå ¹æ±¤°æ °Ë»ç¡¤¿ä°ü°æ °Ë»ç ½ÃÀå - Áö¿ª ºÐ¼®

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ±âŸ ±¹°¡
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • Áß³²¹Ì
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ Áß³²¹Ì

Á¦13Àå °æÀï ±¸µµ

  • È÷Æ®¸Ê ºÐ¼® : ÁÖ¿ä ±â¾÷º°
  • ±â¾÷ÀÇ Æ÷Áö¼Å´×°ú ÁýÁßµµ

Á¦14Àå ¾÷°è »óȲ

  • ¼¼°èÀÇ ¹æ±¤°æ °Ë»ç¡¤¿ä°ü°æ °Ë»ç ½ÃÀå¿¡¼­ÀÇ ¼ºÀå Àü·«
  • À¯±âÀû ¼ºÀå Àü·«
  • ¹«±âÀû ¼ºÀå Àü·«

Á¦15Àå ±â¾÷ °³¿ä

  • Olympus Corp
  • Karl Storz SE & Co KG
  • Richard Wolf GmbH.
  • Ambu A/S
  • PENTAX Medical
  • Advin Health Care Pvt Ltd
  • Coloplast Corp
  • Cook Medical Holdings LLC
  • Electronics Services Centre(ESC Medicams)
  • Stryker Corp
  • Rudra Surgicals
  • Laborie
  • Teleflex Inc
  • NIDHI MEDITECH SYSTEMS
  • Pioneer Healthcare Technologies
  • Boston Scientific Corp
  • Ottomed Endoscopy
  • Becton Dickinson and Co
  • SCHOLLY FIBEROPTIC GMBH
  • MicroPort Scientific Corp

Á¦16Àå ºÎ·Ï

KSA 25.09.16

The cystoscopy and ureteroscopy market is anticipated to grow from US$ 459.11 million in 2024 to US$ 729.30 million by 2031; the market is expected to register a CAGR of 6.9% from 2025 to 2031. The cystoscopy and ureteroscopy market growth are attributed to the increasing prevalence of hearing loss and surging strategic initiatives by market players.

Cystoscopy and ureteroscopy are at the forefront of modern urological care, offering targeted solutions for diagnosing and treating a wide range of urinary tract conditions. These procedures leverage cutting-edge technology through the use of flexible and rigid scopes equipped with high-definition cameras and illumination systems, allowing clinicians to achieve unparalleled visualization of the bladder and urethra.

The cystoscopy and ureteroscopy market in North America is segmented into the US, Canada, and Mexico. The North America cystoscopy and ureteroscopy market is expanding owing to several factors. The US holds the largest market share, followed by Canada. The demand for cystoscopy and ureteroscopy in the region is fueled by the increasing incidence of kidney stones (urolithiasis), bladder cancer, and urinary tract infections.

Advanced technologies, such as Blue Light Cystoscopy, enhance the visualization of bladder cancer lesions beyond what traditional white light can provide. Additionally, the integration of laser systems for stone fragmentation during ureteroscopy highlights the shift toward more sophisticated diagnostic and therapeutic options. Robotics and wireless connectivity offer improved precision, ergonomics, and the capacity for remote diagnostics. Leading medical device manufacturers such as Olympus, KARL STORZ, Boston Scientific, and FUJIFILM spur continuous R&D and strategic collaborations to accelerate product launches and market penetration.

In North America, the US holds a significant share of the cystoscopy and ureteroscopy market. The US dominated the North America cystoscopy and ureteroscopy market in 2024. According to the Department of Urology (University of Florida Health), kidney stones impact 1 in 500 individuals in the US each year. Approximately 1 in 8 men and 1 in 16 women usually develop this condition during their lifetime. The increasing prevalence of kidney stones boosts the demand for cystoscopy and ureteroscopy for early diagnosis and treatment.

According to the National Library of Medicine, UTIs are the most common outpatient infections in the US. The occurrence of UTIs generally increases with age. About 20% of women over 65 experience UTIs, compared to approximately 11% in the overall population. Nearly 50-60% of adult women generally suffer from UTIs at least once in their lifetime.

Recent developments in ureteroscopies and cystoscopies in the US were predominantly made on the technology front to enable more minimally invasive, precise, and patient-centered care. Further, robotic cystoscopes are gaining traction in the medical field, with single-use and robotic-assisted systems offering advancements in cystoscopy procedures. In August 2024, PROCEPT BioRobotics Corporation announced FDA 510(k) clearance of its next-generation platform, the HYDROS Robotic System. The HYDROS Robotic System is the only AI-powered platform for Aquablation therapy for benign prostatic hyperplasia (BPH). This proven procedure uses real-time ultrasound and cystoscopy in assisting surgeons by providing a detailed view of the prostate, allowing for personalized treatment. With over 400 robotic systems installed, Aquablation therapy has gained remarkable popularity in the US.

The development of flexible ureteroscopes with enhanced imaging capabilities and reduced diameters by prominent industry players-including Karl Storz, Olympus, Stryker, and Richard Wolf-has markedly accelerated growth within the urological device market. These technological advancements offer improved procedural navigation, reduced patient discomfort, and heightened visual clarity during interventions. Olympus obtained regulatory clearance in the United States for its innovative single-use ureteroscope system, RenaFlex, in April 2024. This state-of-the-art solution is designed to provide efficient access to the urinary tract for diagnosing and treating conditions such as kidney stones, utilizing either transurethral or percutaneous techniques.

The rising prevalence of urinary tract disorders, combined with the launch of such advanced medical technologies, continues to fuel the expansion of the cystoscopy and ureteroscopy segment across the US healthcare landscape.

Shift Toward Robotic-Assisted Urological Surgeries to Provide Market Opportunities in Future

Robotic surgery, particularly with the use of the da Vinci surgical system, is gaining popularity in urological procedures due to its precision, minimal invasiveness, and ability to reduce recovery times. Robotic systems offer greater control, enhanced visualization, and improved dexterity for surgeons, which are crucial when performing delicate procedures such as cystoscopy and ureteroscopy. Advanced robotic-assisted systems in hospitals also contribute to the increase in minimally invasive procedures, benefitting patients by lowering discomfort, shortening hospital stays, and accelerating recovery. In August 2024, PROCEPT BioRobotics Corporation announced the clearance of its HYDROS Robotic System. This next-generation platform features FirstAssist AI treatment planning, advanced image guidance, and robotic resection, making it the only AI-powered system for aquablation therapy for benign prostatic hyperplasia (BPH). The procedure combines real-time ultrasound imaging and cystoscopy, offering surgeons a detailed view of the prostate for personalized treatment planning. Robotic surgeries also aid relief for healthcare providers by keeping a check on blood loss, shortening operating times, and mitigating postoperative complications.

In May 2024, the American University of Beirut Medical Center's Division of Urology shared its initial impressions of the ILY robotic system used for flexible ureteroscopy to treat kidney stones. The robot is operated via an ergonomic wireless joystick controller, which resembles controllers from popular gaming systems such as Xbox or PlayStation. The surgical team reported a stone-free rate of 93.55%, with no patients requiring reoperation for the treated stones. Based on these findings, the ILY robotic flexible ureteroscopy is claimed to be safe and effective. In emerging economy such as India, there were nearly 76 fully functional surgical robots and over 500 surgeons trained to carry out robotic surgeries as of 2021. The Asian Institute of Nephrology and Urology (AINU, India) is a world-class hospital specializing in urology. The AINU is renowned for its expertise in robotic surgery, particularly in the field of prostate-related conditions, making it home to the best surgeons trained in robotically aided procedures. As technology becomes more affordable and accessible, smaller hospitals and clinics also show interest in robotic systems. Thus, the increasing adoption of robotic-assisted surgeries is emerging as a key trend in the cystoscopy and ureteroscopy market.

The US Food and Drug Administration, International Agency For Research On Cancer, American Urological Association, European Association of Urology, Urological Association of Asia, Urology Care Foundation are among the primary and secondary sources referred to while preparing the cystoscopy and ureteroscopy market report.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Analyst Market Outlook
  • 2.2 Market Attractiveness

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.1 Macro-economic factor analysis:
    • 3.2.2 Developing base number:
    • 3.2.3 Data Triangulation:
    • 3.2.4 Country level data:
  • 3.3 Assumptions and Limitations

4. Cystoscopy and Ureteroscopy Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Cystoscopy and Ureteroscopy Market - Key Market Dynamics

  • 5.1 Cystoscopy and Ureteroscopy Market - Key Market Dynamics
  • 5.2 Market Drivers:
    • 5.2.1 Increasing Prevalence of Urological Diseases
    • 5.2.2 Development of Technologically Advanced and Minimally Invasive Products
  • 5.3 Market Restraints
    • 5.3.1 High Cost of Equipment and Procedures
  • 5.4 Market Opportunities
    • 5.4.1 Expansion in Emerging Markets
  • 5.5 Future Trends
    • 5.5.1 Shift Toward Robotic-Assisted Urological Surgeries
  • 5.6 Impact of Drivers and Restraints:

6. Cystoscopy and Ureteroscopy Market - Global Market Analysis

  • 6.1 Cystoscopy and Ureteroscopy Market Revenue (US$ Million), 2021-2031
  • 6.2 Cystoscopy and Ureteroscopy Market Forecast Analysis

7. Cystoscopy and Ureteroscopy Market Analysis - by Product Type

  • 7.1 Cystoscope
    • 7.1.1 Overview
    • 7.1.2 Cystoscope: Cystoscopy and Ureteroscopy Market - Revenue and Forecast to 2031 (US$ Million)
      • 7.1.2.1 Global Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Cystoscope
  • 7.2 Ureteroscope
    • 7.2.1 Overview
    • 7.2.2 Ureteroscope: Cystoscopy and Ureteroscopy Market - Revenue and Forecast to 2031 (US$ Million)
      • 7.2.2.1 Global Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Ureteroscope

8. Cystoscopy and Ureteroscopy Market Analysis - by Procedure

  • 8.1 Stone Management
    • 8.1.1 Overview
    • 8.1.2 Stone Management: Cystoscopy and Ureteroscopy Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Bladder Cancer
    • 8.2.1 Overview
    • 8.2.2 Bladder Cancer: Cystoscopy and Ureteroscopy Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Benign Prostatic Hyperplasia (BPH)
    • 8.3.1 Overview
    • 8.3.2 Benign Prostatic Hyperplasia (BPH): Cystoscopy and Ureteroscopy Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Others
    • 8.4.1 Overview
    • 8.4.2 Others: Cystoscopy and Ureteroscopy Market - Revenue and Forecast to 2031 (US$ Million)

9. Cystoscopy and Ureteroscopy Market Analysis - by Technology

  • 9.1 Fiberoptic
    • 9.1.1 Overview
    • 9.1.2 Fiberoptic: Cystoscopy and Ureteroscopy Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Video
    • 9.2.1 Overview
    • 9.2.2 Video: Cystoscopy and Ureteroscopy Market - Revenue and Forecast to 2031 (US$ Million)

10. Cystoscopy and Ureteroscopy Market Analysis - by Usage Type

  • 10.1 Reusable
    • 10.1.1 Overview
    • 10.1.2 Reusable: Cystoscopy and Ureteroscopy Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Single Use
    • 10.2.1 Overview
    • 10.2.2 Single Use: Cystoscopy and Ureteroscopy Market - Revenue and Forecast to 2031 (US$ Million)

11. Cystoscopy and Ureteroscopy Market Analysis - by End User

  • 11.1 Hospitals
    • 11.1.1 Overview
    • 11.1.2 Hospitals: Cystoscopy and Ureteroscopy Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.2 Ambulatory Surgical Centers
    • 11.2.1 Overview
    • 11.2.2 Ambulatory Surgical Centers: Cystoscopy and Ureteroscopy Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.3 Specialty Clinics
    • 11.3.1 Overview
    • 11.3.2 Specialty Clinics: Cystoscopy and Ureteroscopy Market - Revenue and Forecast to 2031 (US$ Million)

12. Cystoscopy and Ureteroscopy Market - Geographical Analysis

  • 12.1 North America
    • 12.1.1 North America Cystoscopy and Ureteroscopy Market Overview
    • 12.1.2 North America: Cystoscopy and Ureteroscopy Market - Revenue, 2021-2031 (US$ Million)
      • 12.1.2.1 North America: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Product Type
      • 12.1.2.2 North America: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Cystoscope
      • 12.1.2.3 North America: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Ureteroscope
      • 12.1.2.4 North America: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Procedure
      • 12.1.2.5 North America: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Technology
      • 12.1.2.6 North America: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Usage Type
      • 12.1.2.7 North America: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by End User
    • 12.1.3 North America: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Country
      • 12.1.3.1 United States: Cystoscopy and Ureteroscopy Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.1.3.1.1 United States: Cystoscopy and Ureteroscopy Market Breakdown, by Product Type
        • 12.1.3.1.2 United States: Cystoscopy and Ureteroscopy Market Breakdown, by Cystoscope
        • 12.1.3.1.3 United States: Cystoscopy and Ureteroscopy Market Breakdown, by Ureteroscope
        • 12.1.3.1.4 United States: Cystoscopy and Ureteroscopy Market Breakdown, by Procedure
        • 12.1.3.1.5 United States: Cystoscopy and Ureteroscopy Market Breakdown, by Technology
        • 12.1.3.1.6 United States: Cystoscopy and Ureteroscopy Market Breakdown, by Usage Type
        • 12.1.3.1.7 United States: Cystoscopy and Ureteroscopy Market Breakdown, by End User
      • 12.1.3.2 Canada: Cystoscopy and Ureteroscopy Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.1.3.2.1 Canada: Cystoscopy and Ureteroscopy Market Breakdown, by Product Type
        • 12.1.3.2.2 Canada: Cystoscopy and Ureteroscopy Market Breakdown, by Cystoscope
        • 12.1.3.2.3 Canada: Cystoscopy and Ureteroscopy Market Breakdown, by Ureteroscope
        • 12.1.3.2.4 Canada: Cystoscopy and Ureteroscopy Market Breakdown, by Procedure
        • 12.1.3.2.5 Canada: Cystoscopy and Ureteroscopy Market Breakdown, by Technology
        • 12.1.3.2.6 Canada: Cystoscopy and Ureteroscopy Market Breakdown, by Usage Type
        • 12.1.3.2.7 Canada: Cystoscopy and Ureteroscopy Market Breakdown, by End User
      • 12.1.3.3 Mexico: Cystoscopy and Ureteroscopy Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.1.3.3.1 Mexico: Cystoscopy and Ureteroscopy Market Breakdown, by Product Type
        • 12.1.3.3.2 Mexico: Cystoscopy and Ureteroscopy Market Breakdown, by Cystoscope
        • 12.1.3.3.3 Mexico: Cystoscopy and Ureteroscopy Market Breakdown, by Ureteroscope
        • 12.1.3.3.4 Mexico: Cystoscopy and Ureteroscopy Market Breakdown, by Procedure
        • 12.1.3.3.5 Mexico: Cystoscopy and Ureteroscopy Market Breakdown, by Technology
        • 12.1.3.3.6 Mexico: Cystoscopy and Ureteroscopy Market Breakdown, by Usage Type
        • 12.1.3.3.7 Mexico: Cystoscopy and Ureteroscopy Market Breakdown, by End User
  • 12.2 Europe
    • 12.2.1 Europe Cystoscopy and Ureteroscopy Market Overview
    • 12.2.2 Europe: Cystoscopy and Ureteroscopy Market - Revenue, 2021-2031 (US$ Million)
      • 12.2.2.1 Europe: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Product Type
      • 12.2.2.2 Europe: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Cystoscope
      • 12.2.2.3 Europe: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Ureteroscope
      • 12.2.2.4 Europe: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Procedure
      • 12.2.2.5 Europe: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Technology
      • 12.2.2.6 Europe: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Usage Type
      • 12.2.2.7 Europe: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by End User
    • 12.2.3 Europe: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Country
      • 12.2.3.1 Germany: Cystoscopy and Ureteroscopy Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.2.3.1.1 Germany: Cystoscopy and Ureteroscopy Market Breakdown, by Product Type
        • 12.2.3.1.2 Germany: Cystoscopy and Ureteroscopy Market Breakdown, by Cystoscope
        • 12.2.3.1.3 Germany: Cystoscopy and Ureteroscopy Market Breakdown, by Ureteroscope
        • 12.2.3.1.4 Germany: Cystoscopy and Ureteroscopy Market Breakdown, by Procedure
        • 12.2.3.1.5 Germany: Cystoscopy and Ureteroscopy Market Breakdown, by Technology
        • 12.2.3.1.6 Germany: Cystoscopy and Ureteroscopy Market Breakdown, by Usage Type
        • 12.2.3.1.7 Germany: Cystoscopy and Ureteroscopy Market Breakdown, by End User
      • 12.2.3.2 United Kingdom: Cystoscopy and Ureteroscopy Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.2.3.2.1 United Kingdom: Cystoscopy and Ureteroscopy Market Breakdown, by Product Type
        • 12.2.3.2.2 United Kingdom: Cystoscopy and Ureteroscopy Market Breakdown, by Cystoscope
        • 12.2.3.2.3 United Kingdom: Cystoscopy and Ureteroscopy Market Breakdown, by Ureteroscope
        • 12.2.3.2.4 United Kingdom: Cystoscopy and Ureteroscopy Market Breakdown, by Procedure
        • 12.2.3.2.5 United Kingdom: Cystoscopy and Ureteroscopy Market Breakdown, by Technology
        • 12.2.3.2.6 United Kingdom: Cystoscopy and Ureteroscopy Market Breakdown, by Usage Type
        • 12.2.3.2.7 United Kingdom: Cystoscopy and Ureteroscopy Market Breakdown, by End User
      • 12.2.3.3 France: Cystoscopy and Ureteroscopy Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.2.3.3.1 France: Cystoscopy and Ureteroscopy Market Breakdown, by Product Type
        • 12.2.3.3.2 France: Cystoscopy and Ureteroscopy Market Breakdown, by Cystoscope
        • 12.2.3.3.3 France: Cystoscopy and Ureteroscopy Market Breakdown, by Ureteroscope
        • 12.2.3.3.4 France: Cystoscopy and Ureteroscopy Market Breakdown, by Procedure
        • 12.2.3.3.5 France: Cystoscopy and Ureteroscopy Market Breakdown, by Technology
        • 12.2.3.3.6 France: Cystoscopy and Ureteroscopy Market Breakdown, by Usage Type
        • 12.2.3.3.7 France: Cystoscopy and Ureteroscopy Market Breakdown, by End User
      • 12.2.3.4 Italy: Cystoscopy and Ureteroscopy Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.2.3.4.1 Italy: Cystoscopy and Ureteroscopy Market Breakdown, by Product Type
        • 12.2.3.4.2 Italy: Cystoscopy and Ureteroscopy Market Breakdown, by Cystoscope
        • 12.2.3.4.3 Italy: Cystoscopy and Ureteroscopy Market Breakdown, by Ureteroscope
        • 12.2.3.4.4 Italy: Cystoscopy and Ureteroscopy Market Breakdown, by Procedure
        • 12.2.3.4.5 Italy: Cystoscopy and Ureteroscopy Market Breakdown, by Technology
        • 12.2.3.4.6 Italy: Cystoscopy and Ureteroscopy Market Breakdown, by Usage Type
        • 12.2.3.4.7 Italy: Cystoscopy and Ureteroscopy Market Breakdown, by End User
      • 12.2.3.5 Spain: Cystoscopy and Ureteroscopy Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.2.3.5.1 Spain: Cystoscopy and Ureteroscopy Market Breakdown, by Product Type
        • 12.2.3.5.2 Spain: Cystoscopy and Ureteroscopy Market Breakdown, by Cystoscope
        • 12.2.3.5.3 Spain: Cystoscopy and Ureteroscopy Market Breakdown, by Ureteroscope
        • 12.2.3.5.4 Spain: Cystoscopy and Ureteroscopy Market Breakdown, by Procedure
        • 12.2.3.5.5 Spain: Cystoscopy and Ureteroscopy Market Breakdown, by Technology
        • 12.2.3.5.6 Spain: Cystoscopy and Ureteroscopy Market Breakdown, by Usage Type
        • 12.2.3.5.7 Spain: Cystoscopy and Ureteroscopy Market Breakdown, by End User
      • 12.2.3.6 Rest of Europe: Cystoscopy and Ureteroscopy Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.2.3.6.1 Rest of Europe: Cystoscopy and Ureteroscopy Market Breakdown, by Product Type
        • 12.2.3.6.2 Rest of Europe: Cystoscopy and Ureteroscopy Market Breakdown, by Cystoscope
        • 12.2.3.6.3 Rest of Europe: Cystoscopy and Ureteroscopy Market Breakdown, by Ureteroscope
        • 12.2.3.6.4 Rest of Europe: Cystoscopy and Ureteroscopy Market Breakdown, by Procedure
        • 12.2.3.6.5 Rest of Europe: Cystoscopy and Ureteroscopy Market Breakdown, by Technology
        • 12.2.3.6.6 Rest of Europe: Cystoscopy and Ureteroscopy Market Breakdown, by Usage Type
        • 12.2.3.6.7 Rest of Europe: Cystoscopy and Ureteroscopy Market Breakdown, by End User
  • 12.3 Asia Pacific
    • 12.3.1 Asia Pacific Cystoscopy and Ureteroscopy Market Overview
    • 12.3.2 Asia Pacific: Cystoscopy and Ureteroscopy Market - Revenue, 2021-2031 (US$ Million)
      • 12.3.2.1 Asia Pacific: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Product Type
      • 12.3.2.2 Asia Pacific: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Cystoscope
      • 12.3.2.3 Asia Pacific: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Ureteroscope
      • 12.3.2.4 Asia Pacific: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Procedure
      • 12.3.2.5 Asia Pacific: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Technology
      • 12.3.2.6 Asia Pacific: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Usage Type
      • 12.3.2.7 Asia Pacific: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by End User
    • 12.3.3 Asia Pacific: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Country
      • 12.3.3.1 China: Cystoscopy and Ureteroscopy Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.3.3.1.1 China: Cystoscopy and Ureteroscopy Market Breakdown, by Product Type
        • 12.3.3.1.2 China: Cystoscopy and Ureteroscopy Market Breakdown, by Cystoscope
        • 12.3.3.1.3 China: Cystoscopy and Ureteroscopy Market Breakdown, by Ureteroscope
        • 12.3.3.1.4 China: Cystoscopy and Ureteroscopy Market Breakdown, by Procedure
        • 12.3.3.1.5 China: Cystoscopy and Ureteroscopy Market Breakdown, by Technology
        • 12.3.3.1.6 China: Cystoscopy and Ureteroscopy Market Breakdown, by Usage Type
        • 12.3.3.1.7 China: Cystoscopy and Ureteroscopy Market Breakdown, by End User
      • 12.3.3.2 Japan: Cystoscopy and Ureteroscopy Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.3.3.2.1 Japan: Cystoscopy and Ureteroscopy Market Breakdown, by Product Type
        • 12.3.3.2.2 Japan: Cystoscopy and Ureteroscopy Market Breakdown, by Cystoscope
        • 12.3.3.2.3 Japan: Cystoscopy and Ureteroscopy Market Breakdown, by Ureteroscope
        • 12.3.3.2.4 Japan: Cystoscopy and Ureteroscopy Market Breakdown, by Procedure
        • 12.3.3.2.5 Japan: Cystoscopy and Ureteroscopy Market Breakdown, by Technology
        • 12.3.3.2.6 Japan: Cystoscopy and Ureteroscopy Market Breakdown, by Usage Type
        • 12.3.3.2.7 Japan: Cystoscopy and Ureteroscopy Market Breakdown, by End User
      • 12.3.3.3 India: Cystoscopy and Ureteroscopy Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.3.3.3.1 India: Cystoscopy and Ureteroscopy Market Breakdown, by Product Type
        • 12.3.3.3.2 India: Cystoscopy and Ureteroscopy Market Breakdown, by Cystoscope
        • 12.3.3.3.3 India: Cystoscopy and Ureteroscopy Market Breakdown, by Ureteroscope
        • 12.3.3.3.4 India: Cystoscopy and Ureteroscopy Market Breakdown, by Procedure
        • 12.3.3.3.5 India: Cystoscopy and Ureteroscopy Market Breakdown, by Technology
        • 12.3.3.3.6 India: Cystoscopy and Ureteroscopy Market Breakdown, by Usage Type
        • 12.3.3.3.7 India: Cystoscopy and Ureteroscopy Market Breakdown, by End User
      • 12.3.3.4 Australia: Cystoscopy and Ureteroscopy Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.3.3.4.1 Australia: Cystoscopy and Ureteroscopy Market Breakdown, by Product Type
        • 12.3.3.4.2 Australia: Cystoscopy and Ureteroscopy Market Breakdown, by Cystoscope
        • 12.3.3.4.3 Australia: Cystoscopy and Ureteroscopy Market Breakdown, by Ureteroscope
        • 12.3.3.4.4 Australia: Cystoscopy and Ureteroscopy Market Breakdown, by Procedure
        • 12.3.3.4.5 Australia: Cystoscopy and Ureteroscopy Market Breakdown, by Technology
        • 12.3.3.4.6 Australia: Cystoscopy and Ureteroscopy Market Breakdown, by Usage Type
        • 12.3.3.4.7 Australia: Cystoscopy and Ureteroscopy Market Breakdown, by End User
      • 12.3.3.5 South Korea: Cystoscopy and Ureteroscopy Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.3.3.5.1 South Korea: Cystoscopy and Ureteroscopy Market Breakdown, by Product Type
        • 12.3.3.5.2 South Korea: Cystoscopy and Ureteroscopy Market Breakdown, by Cystoscope
        • 12.3.3.5.3 South Korea: Cystoscopy and Ureteroscopy Market Breakdown, by Ureteroscope
        • 12.3.3.5.4 South Korea: Cystoscopy and Ureteroscopy Market Breakdown, by Procedure
        • 12.3.3.5.5 South Korea: Cystoscopy and Ureteroscopy Market Breakdown, by Technology
        • 12.3.3.5.6 South Korea: Cystoscopy and Ureteroscopy Market Breakdown, by Usage Type
        • 12.3.3.5.7 South Korea: Cystoscopy and Ureteroscopy Market Breakdown, by End User
      • 12.3.3.6 Rest of APAC: Cystoscopy and Ureteroscopy Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.3.3.6.1 Rest of APAC: Cystoscopy and Ureteroscopy Market Breakdown, by Product Type
        • 12.3.3.6.2 Rest of APAC: Cystoscopy and Ureteroscopy Market Breakdown, by Cystoscope
        • 12.3.3.6.3 Rest of APAC: Cystoscopy and Ureteroscopy Market Breakdown, by Ureteroscope
        • 12.3.3.6.4 Rest of APAC: Cystoscopy and Ureteroscopy Market Breakdown, by Procedure
        • 12.3.3.6.5 Rest of APAC: Cystoscopy and Ureteroscopy Market Breakdown, by Technology
        • 12.3.3.6.6 Rest of APAC: Cystoscopy and Ureteroscopy Market Breakdown, by Usage Type
        • 12.3.3.6.7 Rest of APAC: Cystoscopy and Ureteroscopy Market Breakdown, by End User
  • 12.4 Middle East and Africa
    • 12.4.1 Middle East and Africa Cystoscopy and Ureteroscopy Market Overview
    • 12.4.2 Middle East and Africa: Cystoscopy and Ureteroscopy Market - Revenue, 2021-2031 (US$ Million)
      • 12.4.2.1 Middle East and Africa: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Product Type
      • 12.4.2.2 Middle East and Africa: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Cystoscope
      • 12.4.2.3 Middle East and Africa: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Ureteroscope
      • 12.4.2.4 Middle East and Africa: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Procedure
      • 12.4.2.5 Middle East and Africa: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Technology
      • 12.4.2.6 Middle East and Africa: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Usage Type
      • 12.4.2.7 Middle East and Africa: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by End User
    • 12.4.3 Middle East and Africa: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Country
      • 12.4.3.1 Saudi Arabia: Cystoscopy and Ureteroscopy Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.4.3.1.1 Saudi Arabia: Cystoscopy and Ureteroscopy Market Breakdown, by Product Type
        • 12.4.3.1.2 Saudi Arabia: Cystoscopy and Ureteroscopy Market Breakdown, by Cystoscope
        • 12.4.3.1.3 Saudi Arabia: Cystoscopy and Ureteroscopy Market Breakdown, by Ureteroscope
        • 12.4.3.1.4 Saudi Arabia: Cystoscopy and Ureteroscopy Market Breakdown, by Procedure
        • 12.4.3.1.5 Saudi Arabia: Cystoscopy and Ureteroscopy Market Breakdown, by Technology
        • 12.4.3.1.6 Saudi Arabia: Cystoscopy and Ureteroscopy Market Breakdown, by Usage Type
        • 12.4.3.1.7 Saudi Arabia: Cystoscopy and Ureteroscopy Market Breakdown, by End User
      • 12.4.3.2 South Africa: Cystoscopy and Ureteroscopy Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.4.3.2.1 South Africa: Cystoscopy and Ureteroscopy Market Breakdown, by Product Type
        • 12.4.3.2.2 South Africa: Cystoscopy and Ureteroscopy Market Breakdown, by Cystoscope
        • 12.4.3.2.3 South Africa: Cystoscopy and Ureteroscopy Market Breakdown, by Ureteroscope
        • 12.4.3.2.4 South Africa: Cystoscopy and Ureteroscopy Market Breakdown, by Procedure
        • 12.4.3.2.5 South Africa: Cystoscopy and Ureteroscopy Market Breakdown, by Technology
        • 12.4.3.2.6 South Africa: Cystoscopy and Ureteroscopy Market Breakdown, by Usage Type
        • 12.4.3.2.7 South Africa: Cystoscopy and Ureteroscopy Market Breakdown, by End User
      • 12.4.3.3 United Arab Emirates: Cystoscopy and Ureteroscopy Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.4.3.3.1 United Arab Emirates: Cystoscopy and Ureteroscopy Market Breakdown, by Product Type
        • 12.4.3.3.2 United Arab Emirates: Cystoscopy and Ureteroscopy Market Breakdown, by Cystoscope
        • 12.4.3.3.3 United Arab Emirates: Cystoscopy and Ureteroscopy Market Breakdown, by Ureteroscope
        • 12.4.3.3.4 United Arab Emirates: Cystoscopy and Ureteroscopy Market Breakdown, by Procedure
        • 12.4.3.3.5 United Arab Emirates: Cystoscopy and Ureteroscopy Market Breakdown, by Technology
        • 12.4.3.3.6 United Arab Emirates: Cystoscopy and Ureteroscopy Market Breakdown, by Usage Type
        • 12.4.3.3.7 United Arab Emirates: Cystoscopy and Ureteroscopy Market Breakdown, by End User
      • 12.4.3.4 Rest of Middle East and Africa: Cystoscopy and Ureteroscopy Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.4.3.4.1 Rest of Middle East and Africa: Cystoscopy and Ureteroscopy Market Breakdown, by Product Type
        • 12.4.3.4.2 Rest of Middle East and Africa: Cystoscopy and Ureteroscopy Market Breakdown, by Cystoscope
        • 12.4.3.4.3 Rest of Middle East and Africa: Cystoscopy and Ureteroscopy Market Breakdown, by Ureteroscope
        • 12.4.3.4.4 Rest of Middle East and Africa: Cystoscopy and Ureteroscopy Market Breakdown, by Procedure
        • 12.4.3.4.5 Rest of Middle East and Africa: Cystoscopy and Ureteroscopy Market Breakdown, by Technology
        • 12.4.3.4.6 Rest of Middle East and Africa: Cystoscopy and Ureteroscopy Market Breakdown, by Usage Type
        • 12.4.3.4.7 Rest of Middle East and Africa: Cystoscopy and Ureteroscopy Market Breakdown, by End User
  • 12.5 South and Central America
    • 12.5.1 South and Central America Cystoscopy and Ureteroscopy Market Overview
    • 12.5.2 South and Central America: Cystoscopy and Ureteroscopy Market - Revenue, 2021-2031 (US$ Million)
      • 12.5.2.1 South and Central America: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Product Type
      • 12.5.2.2 South and Central America: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Cystoscope
      • 12.5.2.3 South and Central America: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Ureteroscope
      • 12.5.2.4 South and Central America: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Procedure
      • 12.5.2.5 South and Central America: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Technology
      • 12.5.2.6 South and Central America: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Usage Type
      • 12.5.2.7 South and Central America: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by End User
    • 12.5.3 South and Central America: Cystoscopy and Ureteroscopy Market - Revenue and Forecast Analysis - by Country
      • 12.5.3.1 Brazil: Cystoscopy and Ureteroscopy Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.5.3.1.1 Brazil: Cystoscopy and Ureteroscopy Market Breakdown, by Product Type
        • 12.5.3.1.2 Brazil: Cystoscopy and Ureteroscopy Market Breakdown, by Cystoscope
        • 12.5.3.1.3 Brazil: Cystoscopy and Ureteroscopy Market Breakdown, by Ureteroscope
        • 12.5.3.1.4 Brazil: Cystoscopy and Ureteroscopy Market Breakdown, by Procedure
        • 12.5.3.1.5 Brazil: Cystoscopy and Ureteroscopy Market Breakdown, by Technology
        • 12.5.3.1.6 Brazil: Cystoscopy and Ureteroscopy Market Breakdown, by Usage Type
        • 12.5.3.1.7 Brazil: Cystoscopy and Ureteroscopy Market Breakdown, by End User
      • 12.5.3.2 Argentina: Cystoscopy and Ureteroscopy Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.5.3.2.1 Argentina: Cystoscopy and Ureteroscopy Market Breakdown, by Product Type
        • 12.5.3.2.2 Argentina: Cystoscopy and Ureteroscopy Market Breakdown, by Cystoscope
        • 12.5.3.2.3 Argentina: Cystoscopy and Ureteroscopy Market Breakdown, by Ureteroscope
        • 12.5.3.2.4 Argentina: Cystoscopy and Ureteroscopy Market Breakdown, by Procedure
        • 12.5.3.2.5 Argentina: Cystoscopy and Ureteroscopy Market Breakdown, by Technology
        • 12.5.3.2.6 Argentina: Cystoscopy and Ureteroscopy Market Breakdown, by Usage Type
        • 12.5.3.2.7 Argentina: Cystoscopy and Ureteroscopy Market Breakdown, by End User
      • 12.5.3.3 Rest of South and Central America: Cystoscopy and Ureteroscopy Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.5.3.3.1 Rest of South and Central America: Cystoscopy and Ureteroscopy Market Breakdown, by Product Type
        • 12.5.3.3.2 Rest of South and Central America: Cystoscopy and Ureteroscopy Market Breakdown, by Cystoscope
        • 12.5.3.3.3 Rest of South and Central America: Cystoscopy and Ureteroscopy Market Breakdown, by Ureteroscope
        • 12.5.3.3.4 Rest of South and Central America: Cystoscopy and Ureteroscopy Market Breakdown, by Procedure
        • 12.5.3.3.5 Rest of South and Central America: Cystoscopy and Ureteroscopy Market Breakdown, by Technology
        • 12.5.3.3.6 Rest of South and Central America: Cystoscopy and Ureteroscopy Market Breakdown, by Usage Type
        • 12.5.3.3.7 Rest of South and Central America: Cystoscopy and Ureteroscopy Market Breakdown, by End User

13. Competitive Landscape

  • 13.1 Heat Map Analysis by Key Players
  • 13.2 Company Positioning & Concentration

14. Industry Landscape

  • 14.1 Overview
  • 14.2 Growth Strategies in the Global Cystoscopy and Ureteroscopy Market
  • 14.3 Organic Growth Strategies
    • 14.3.1 Overview
  • 14.4 Inorganic Growth Strategies
    • 14.4.1 Overview

15. Company Profiles

  • 15.1 Olympus Corp
    • 15.1.1 Key Facts
    • 15.1.2 Business Description
    • 15.1.3 Products and Services
    • 15.1.4 Financial Overview
    • 15.1.5 SWOT Analysis
    • 15.1.6 Key Developments
  • 15.2 Karl Storz SE & Co KG
    • 15.2.1 Key Facts
    • 15.2.2 Business Description
    • 15.2.3 Products and Services
    • 15.2.4 Financial Overview
    • 15.2.5 SWOT Analysis
    • 15.2.6 Key Developments
  • 15.3 Richard Wolf GmbH.
    • 15.3.1 Key Facts
    • 15.3.2 Business Description
    • 15.3.3 Products and Services
    • 15.3.4 Financial Overview
    • 15.3.5 SWOT Analysis
    • 15.3.6 Key Developments
  • 15.4 Ambu A/S
    • 15.4.1 Key Facts
    • 15.4.2 Business Description
    • 15.4.3 Products and Services
    • 15.4.4 Financial Overview
    • 15.4.5 SWOT Analysis
    • 15.4.6 Key Developments
  • 15.5 PENTAX Medical
    • 15.5.1 Key Facts
    • 15.5.2 Business Description
    • 15.5.3 Products and Services
    • 15.5.4 Financial Overview
    • 15.5.5 SWOT Analysis
    • 15.5.6 Key Developments
  • 15.6 Advin Health Care Pvt Ltd
    • 15.6.1 Key Facts
    • 15.6.2 Business Description
    • 15.6.3 Products and Services
    • 15.6.4 Financial Overview
    • 15.6.5 SWOT Analysis
    • 15.6.6 Key Developments
  • 15.7 Coloplast Corp
    • 15.7.1 Key Facts
    • 15.7.2 Business Description
    • 15.7.3 Products and Services
    • 15.7.4 Financial Overview
    • 15.7.5 SWOT Analysis
    • 15.7.6 Key Developments
  • 15.8 Cook Medical Holdings LLC
    • 15.8.1 Key Facts
    • 15.8.2 Business Description
    • 15.8.3 Products and Services
    • 15.8.4 Financial Overview
    • 15.8.5 SWOT Analysis
    • 15.8.6 Key Developments
  • 15.9 Electronics Services Centre (ESC Medicams)
    • 15.9.1 Key Facts
    • 15.9.2 Business Description
    • 15.9.3 Products and Services
    • 15.9.4 Financial Overview
    • 15.9.5 SWOT Analysis
    • 15.9.6 Key Developments
  • 15.10 Stryker Corp
    • 15.10.1 Key Facts
    • 15.10.2 Business Description
    • 15.10.3 Products and Services
    • 15.10.4 Financial Overview
    • 15.10.5 SWOT Analysis
    • 15.10.6 Key Developments
  • 15.11 Rudra Surgicals
    • 15.11.1 Key Facts
    • 15.11.2 Business Description
    • 15.11.3 Products and Services
    • 15.11.4 Financial Overview
    • 15.11.5 SWOT Analysis
    • 15.11.6 Key Developments
  • 15.12 Laborie
    • 15.12.1 Key Facts
    • 15.12.2 Business Description
    • 15.12.3 Products and Services
    • 15.12.4 Financial Overview
    • 15.12.5 SWOT Analysis
    • 15.12.6 Key Developments
  • 15.13 Teleflex Inc
    • 15.13.1 Key Facts
    • 15.13.2 Business Description
    • 15.13.3 Products and Services
    • 15.13.4 Financial Overview
    • 15.13.5 SWOT Analysis
    • 15.13.6 Key Developments
  • 15.14 NIDHI MEDITECH SYSTEMS
    • 15.14.1 Key Facts
    • 15.14.2 Business Description
    • 15.14.3 Products and Services
    • 15.14.4 Financial Overview
    • 15.14.5 SWOT Analysis
    • 15.14.6 Key Developments
  • 15.15 Pioneer Healthcare Technologies
    • 15.15.1 Key Facts
    • 15.15.2 Business Description
    • 15.15.3 Products and Services
    • 15.15.4 Financial Overview
    • 15.15.5 SWOT Analysis
    • 15.15.6 Key Developments
  • 15.16 Boston Scientific Corp
    • 15.16.1 Key Facts
    • 15.16.2 Business Description
    • 15.16.3 Products and Services
    • 15.16.4 Financial Overview
    • 15.16.5 SWOT Analysis
    • 15.16.6 Key Developments
  • 15.17 Ottomed Endoscopy
    • 15.17.1 Key Facts
    • 15.17.2 Business Description
    • 15.17.3 Products and Services
    • 15.17.4 Financial Overview
    • 15.17.5 SWOT Analysis
    • 15.17.6 Key Developments
  • 15.18 Becton Dickinson and Co
    • 15.18.1 Key Facts
    • 15.18.2 Business Description
    • 15.18.3 Products and Services
    • 15.18.4 Financial Overview
    • 15.18.5 SWOT Analysis
    • 15.18.6 Key Developments
  • 15.19 SCHOLLY FIBEROPTIC GMBH
    • 15.19.1 Key Facts
    • 15.19.2 Business Description
    • 15.19.3 Products and Services
    • 15.19.4 Financial Overview
    • 15.19.5 SWOT Analysis
    • 15.19.6 Key Developments
  • 15.20 MicroPort Scientific Corp
    • 15.20.1 Key Facts
    • 15.20.2 Business Description
    • 15.20.3 Products and Services
    • 15.20.4 Financial Overview
    • 15.20.5 SWOT Analysis
    • 15.20.6 Key Developments

16. Appendix

  • 16.1 About The Insight Partners
  • 16.2 Glossary of Terms
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦